Association of Ambulance Chief Executives
The Association of Ambulance Chief Executives (AACE) is undertaking a full review of the JRCALC glycaemic emergencies' guideline, specifically the hypoglycaemia management flowchart, to revise it to include detail on hospital conveyance and address time discrepancies. AACE has also shared the coroner's concerns with all UK ambulance services and highlighted them at a national medical directors' meeting to raise awareness.
View full response
[Page 2] currently reviewing the sections of guideline that relate to hypoglycaemia management. Registered paramedics will contribute to this review process to ensure clarity and ease of implementation. On initial review of the guideline, we agree that the hypoglycaemia management flowchart does not contain detail of considerations of whether the patient needs to go to hospital. We are looking to revise this specifically as well as considering the guideline in its entirety. We will also address the different time thresholds for administration of IV glucose that you highlighted as a discrepancy. Our aim is to complete our review and subsequent update of the glycaemic emergencies’ guideline over the next few months. The revised guideline will be presented to JRCALC for approval, and then for final ratification by the national ambulance services medical directors’ group (NASMeD). New and updated guidelines are released onto the JRCALC App at regular intervals throughout the year. Ambulance services are given at least four weeks’ notice of planned updates via senior clinicians so that they can prepare accordingly and consider any local education that may be required to support new guidance. Another action we have taken was to share your matters of concern by email with all UK ambulance services via medical directors and quality and risk directors. We suggested that they consider raising awareness amongst clinicians of the risks of not conveying a patient to hospital after a hypoglycaemic episode, particularly if a patient is taking sulphonylurea medications. In addition to this, we highlighted the concerns you raised at the national ambulance service medical directors (NASMeD) meeting on 18 August. I hope this is helpful. Please do not hesitate to contact me should you require any further information.